Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
Shirley D’Sa, Professor of Haematology at United KingdomUnited Kingdom, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Hematology Reports, adding:
”Treatment options following BTK inhibitor failure in Waldenström macroglobulinaemia (WM) remain an important unmet need in our field.
Our recently published article explores the role of bortezomib-based therapy in patients who have progressed following BTKi treatment, providing valuable real-world evidence in an area where prospective data remain limited.
As the therapeutic landscape of WM continues to evolve—with non-covalent BTK inhibitors, BTK degraders, BCL2 inhibitors, bispecific antibodies and cellular therapies all under investigation—it is important not to overlook the potential utility of established agents such as proteasome inhibitors.
The paper contributes to the growing discussion around treatment sequencing in WM and the question many of us increasingly face in clinical practice: what comes after BTKi?
An interesting read for anyone involved in the care of patients with WM and related IgM disorders.”
Title: Bortezomib in Patients Who Fail BTKi in Waldenström Macroglobulinaemia
Authors: Tahanzaib Khwaja, Nicole Japzon, Simona Gatto, Jindriska Lindsay, Charalampia Kyriakou, Shirley D’Sa
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 23:39Paul Tortland: What a New PRP Study Really Tells Us About Knee Osteoarthritis
-
Oct 28, 2026, 23:34Jawad Derbas: Comparing Mechanical and Pharmacomechanical VTE Prophylaxis in Spine Surgery
-
Oct 28, 2026, 23:31Giulio Maria Pasinetti: Aspirin Use Linked to Lower Dementia Risk in Older Adults With Specific Genetic Characteristics
-
Oct 28, 2026, 23:27Ralf Ludwig: Targeting Neutrophil-Driven Autoimmunity Through CDK Inhibition
-
Oct 28, 2026, 23:26Houda Moustaide: Great Discussions During Our Training Day on Thrombocytopenia in Pregnancy
-
Oct 28, 2026, 23:22Keith Berelowitz: Building Better Medicines by Listening to Patients With Bleeding Disorders
-
Oct 28, 2026, 23:19Nickie Enos: Blood Clots in Arteries and Veins Differ in Symptoms and Treatment
-
Oct 28, 2026, 23:17David Rosenblum: Can Concentrated PRP Actually Cause Scar Tissue?
-
Oct 28, 2026, 23:15Shueh Hao Lim: Advancing Multidisciplinary Care for Venous Thromboembolism in Malaysia